Financial Ratios Intco Medical Technology Co., Ltd.
Equities
300677
CNE100003456
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.92 CNY | -2.82% |
|
-10.70% | +30.90% |
| 04-23 | Intco Medical Technology Q1 net profit down 97.2% y/y | RE |
| 04-23 | Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 31.97 | -0.21 | -0.42 | 1.79 | 1.52 | |||||
Return on Total Capital | 41.05 | -0.26 | -0.49 | 2.03 | 1.7 | |||||
Return On Equity % | 58.39 | 3.97 | 2.4 | 8.78 | 5.78 | |||||
Return on Common Equity | 58.93 | 3.97 | 2.41 | 8.77 | 5.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 61.41 | 12.67 | 13.41 | 22.85 | 23.91 | |||||
SG&A Margin | 5.72 | 9.29 | 10.46 | 8.47 | 9.92 | |||||
EBITDA Margin % | 55.1 | 8.37 | 7.99 | 18.27 | 18.87 | |||||
EBITA Margin % | 52.93 | -0.81 | -2.13 | 9.47 | 9.41 | |||||
EBIT Margin % | 52.85 | -1.06 | -2.35 | 9.3 | 9.16 | |||||
Income From Continuing Operations Margin % | 45.96 | 9.67 | 5.61 | 15.66 | 10.55 | |||||
Net Income Margin % | 45.75 | 9.51 | 5.54 | 15.39 | 10.18 | |||||
Net Avail. For Common Margin % | 45.75 | 9.51 | 5.54 | 15.39 | 10.18 | |||||
Normalized Net Income Margin | 32.98 | 5.85 | 1.94 | 8.76 | 5.17 | |||||
Levered Free Cash Flow Margin | -1.35 | -15.03 | -20.91 | -13.49 | -6.4 | |||||
Unlevered Free Cash Flow Margin | -1.35 | -14.76 | -19.76 | -11.47 | -4.08 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.97 | 0.31 | 0.28 | 0.31 | 0.27 | |||||
Fixed Assets Turnover | 2.74 | 0.77 | 0.76 | 1 | 0.93 | |||||
Receivables Turnover (Average Receivables) | 25.1 | 9.91 | 9.23 | 8.15 | 7.17 | |||||
Inventory Turnover (Average Inventory) | 6.51 | 5.55 | 5.56 | 6.08 | 5.83 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.17 | 3.24 | 1.81 | 1.5 | 0.85 | |||||
Quick Ratio | 4.36 | 2.82 | 1.64 | 1.38 | 0.76 | |||||
Operating Cash Flow to Current Liabilities | 4.17 | 0.34 | 0.06 | 0.07 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 14.54 | 36.84 | 39.55 | 44.92 | 50.9 | |||||
Days Outstanding Inventory (Average Inventory) | 56.1 | 65.81 | 65.61 | 60.16 | 62.65 | |||||
Average Days Payable Outstanding | 58.79 | 69.91 | 55.55 | 43.33 | 50.38 | |||||
Cash Conversion Cycle (Average Days) | 11.84 | 32.74 | 49.61 | 61.75 | 63.16 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.81 | 9.85 | 43.98 | 75.05 | 94.23 | |||||
Total Debt / Total Capital | 1.78 | 8.96 | 30.55 | 42.87 | 48.52 | |||||
LT Debt/Equity | 1.27 | 0.33 | 0.47 | 0.94 | 2.2 | |||||
Long-Term Debt / Total Capital | 1.25 | 0.3 | 0.33 | 0.54 | 1.13 | |||||
Total Liabilities / Total Assets | 21.82 | 25.28 | 39.83 | 48.94 | 53.68 | |||||
EBIT / Interest Expense | - | -2.47 | -1.27 | 2.87 | 2.46 | |||||
EBITDA / Interest Expense | - | 19.55 | 4.36 | 5.66 | 5.08 | |||||
(EBITDA - Capex) / Interest Expense | - | -40.72 | -6.91 | -0.15 | -1.9 | |||||
Total Debt / EBITDA | 0.03 | 2.84 | 12.88 | 7.61 | 9.34 | |||||
Net Debt / EBITDA | -0.89 | -12.03 | -10.81 | -3.15 | 2.3 | |||||
Total Debt / (EBITDA - Capex) | 0.08 | -1.36 | -8.12 | -284.05 | -24.96 | |||||
Net Debt / (EBITDA - Capex) | -2.28 | 5.77 | 6.82 | 117.35 | -6.15 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.37 | -59.27 | 4.61 | 37.65 | 4.23 | |||||
Gross Profit, 1 Yr. Growth % | 4.48 | -91.6 | 10.77 | 130.9 | 9.09 | |||||
EBITDA, 1 Yr. Growth % | 2.18 | -93.82 | -0.77 | 212.34 | 6.32 | |||||
EBITA, 1 Yr. Growth % | -0.31 | -100.62 | 194.38 | -732.92 | 1.13 | |||||
EBIT, 1 Yr. Growth % | -0.4 | -100.82 | 131.2 | -644.83 | 0.8 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 6.55 | -91.43 | -39.3 | 284.39 | -29.8 | |||||
Net Income, 1 Yr. Growth % | 6.04 | -91.53 | -39.12 | 282.63 | -31.03 | |||||
Normalized Net Income, 1 Yr. Growth % | 2.89 | -92.78 | -65.28 | 521.17 | -39.2 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -2.73 | -91.36 | -38.95 | 289.66 | -30.53 | |||||
Accounts Receivable, 1 Yr. Growth % | 49.97 | -28.36 | 68.75 | 47.14 | -0.6 | |||||
Inventory, 1 Yr. Growth % | 27.32 | -6.96 | 14.55 | 10.04 | 4.87 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 131.3 | 7.85 | 3.76 | 5.89 | 18.56 | |||||
Total Assets, 1 Yr. Growth % | 59.45 | 4.14 | 26.08 | 27.89 | 15.76 | |||||
Tangible Book Value, 1 Yr. Growth % | 69.45 | -0.12 | 1.57 | 7.6 | 5.34 | |||||
Common Equity, 1 Yr. Growth % | 69.86 | -0.41 | 1.41 | 8.58 | 4.88 | |||||
Cash From Operations, 1 Yr. Growth % | 1.04 | -87.73 | -52.85 | 114.78 | 74.69 | |||||
Capital Expenditures, 1 Yr. Growth % | 87.68 | -68.49 | -16.12 | 24.38 | 43.89 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -107.68 | 332.06 | 45.55 | -11.19 | -50.17 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -107.26 | 345.64 | 40.03 | -20.08 | -62.62 | |||||
Dividend Per Share, 1 Yr. Growth % | -66.25 | -84.2 | -19 | 87.5 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 179.23 | -30.86 | -34.73 | 20 | 19.78 | |||||
Gross Profit, 2 Yr. CAGR % | 337.49 | -70.38 | -69.5 | 61.17 | 58.71 | |||||
EBITDA, 2 Yr. CAGR % | 438.19 | -74.86 | -75.15 | 76.78 | 83.36 | |||||
EBITA, 2 Yr. CAGR % | 525.11 | -92.14 | -86.92 | 324.87 | 155.99 | |||||
EBIT, 2 Yr. CAGR % | 529.26 | -90.97 | -86.24 | 254.91 | 136.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 547.05 | -69.79 | -77.2 | 52.75 | 64.27 | |||||
Net Income, 2 Yr. CAGR % | 545.51 | -70.04 | -77.3 | 52.63 | 62.45 | |||||
Normalized Net Income, 2 Yr. CAGR % | 566.18 | -72.75 | -84.17 | 46.85 | 95.53 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 479.28 | -71.02 | -77.04 | 54.24 | 64.53 | |||||
Accounts Receivable, 2 Yr. CAGR % | 52.84 | 3.66 | 9.96 | 57.57 | 20.94 | |||||
Inventory, 2 Yr. CAGR % | 115.07 | 8.84 | 3.24 | 12.27 | 7.42 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 173.06 | 57.94 | 5.78 | 4.82 | 12.05 | |||||
Total Assets, 2 Yr. CAGR % | 162.55 | 28.86 | 14.58 | 26.98 | 21.67 | |||||
Tangible Book Value, 2 Yr. CAGR % | 244.8 | 30.1 | 0.72 | 4.54 | 6.46 | |||||
Common Equity, 2 Yr. CAGR % | 227.77 | 30.06 | 0.49 | 4.93 | 6.72 | |||||
Cash From Operations, 2 Yr. CAGR % | 413.11 | -64.78 | -75.94 | 0.64 | 93.7 | |||||
Capital Expenditures, 2 Yr. CAGR % | 218.52 | -23.1 | -48.59 | 2.14 | 33.78 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -17.68 | -40.98 | 150.78 | 13.7 | -33.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -15.35 | -43.14 | 149.8 | 5.79 | -45.6 | |||||
Dividend Per Share, 2 Yr. CAGR % | 235.58 | -76.91 | -64.22 | 23.24 | 36.93 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 104.73 | 46.98 | -20.63 | -16.3 | 14.49 | |||||
Gross Profit, 3 Yr. CAGR % | 177.39 | 17.15 | -54.02 | -39.8 | 41.51 | |||||
EBITDA, 3 Yr. CAGR % | 223.01 | 21.45 | -60.19 | -42.07 | 49.83 | |||||
EBITA, 3 Yr. CAGR % | 257.26 | -37.65 | -74.26 | -52.84 | 165.38 | |||||
EBIT, 3 Yr. CAGR % | 258.7 | -31.3 | -73.38 | -53.1 | 134.73 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 246.54 | 53.07 | -61.88 | -41.53 | 17.88 | |||||
Net Income, 3 Yr. CAGR % | 246.02 | 52.23 | -62.05 | -41.79 | 17.12 | |||||
Normalized Net Income, 3 Yr. CAGR % | 249.81 | 47.42 | -70.46 | -46.2 | 9.9 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 218.42 | 42.57 | -62.85 | -40.99 | 18.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | 35.09 | 18.73 | 21.94 | 21.17 | 35.14 | |||||
Inventory, 3 Yr. CAGR % | 73.35 | 62.66 | 10.71 | 5.46 | 9.75 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 116.79 | 100.34 | 37.3 | 5.82 | 9.21 | |||||
Total Assets, 3 Yr. CAGR % | 104.13 | 92.91 | 27.93 | 18.86 | 23.12 | |||||
Tangible Book Value, 3 Yr. CAGR % | 134.53 | 128.14 | 19.79 | 2.96 | 4.81 | |||||
Common Equity, 3 Yr. CAGR % | 131.87 | 120.35 | 19.71 | 3.12 | 4.92 | |||||
Cash From Operations, 3 Yr. CAGR % | 260.17 | 47.85 | -61.18 | -50.09 | 20.95 | |||||
Capital Expenditures, 3 Yr. CAGR % | 160.33 | 47.31 | -20.84 | -30.99 | 14.5 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -7.55 | 45.42 | -20.26 | 77.43 | -13.86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -6.54 | 47.26 | -23.21 | 70.85 | -25.45 | |||||
Dividend Per Share, 3 Yr. CAGR % | 124.01 | 21.18 | -64.91 | -37.86 | 14.95 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 68.85 | 30.45 | 29.6 | 35.53 | -6.43 | |||||
Gross Profit, 5 Yr. CAGR % | 102.93 | 14.03 | 14.71 | 33.09 | -24.29 | |||||
EBITDA, 5 Yr. CAGR % | 127.68 | 15.81 | 15.78 | 41.3 | -26.54 | |||||
EBITA, 5 Yr. CAGR % | 142.73 | -23.32 | -4.85 | 32.59 | -35.9 | |||||
EBIT, 5 Yr. CAGR % | 143.02 | -18.89 | -2.66 | 32.5 | -36.23 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 144.14 | 34.53 | 16.69 | 52.94 | -31.62 | |||||
Net Income, 5 Yr. CAGR % | 143.92 | 34.1 | 16.39 | 52.39 | -32.11 | |||||
Normalized Net Income, 5 Yr. CAGR % | 143.72 | 29.01 | 1.42 | 47.19 | -37.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 118.97 | 24.14 | 11.23 | 47.13 | -32.62 | |||||
Accounts Receivable, 5 Yr. CAGR % | 30.13 | 18.63 | 24.41 | 32.96 | 21.54 | |||||
Inventory, 5 Yr. CAGR % | 50.16 | 43.97 | 40.89 | 40.24 | 9.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 66.73 | 64.25 | 62.7 | 54.61 | 26.58 | |||||
Total Assets, 5 Yr. CAGR % | 77.71 | 66.91 | 62.03 | 63.19 | 25.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | 97.82 | 70.53 | 67.25 | 66.97 | 14.27 | |||||
Common Equity, 5 Yr. CAGR % | 96.96 | 70.8 | 65.96 | 63.77 | 14.33 | |||||
Cash From Operations, 5 Yr. CAGR % | 154.93 | 33.84 | 22.01 | 26.76 | -26.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 90.79 | 51.88 | 36.06 | 27.24 | -2.35 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 7.88 | 111.99 | 39.16 | 31.79 | -25.95 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 8.74 | 131.59 | 38.49 | 29.01 | -33.1 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 28.86 | 7.55 | 22 | -39.51 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















